Photo by nci from unsplash
We agree that there are very little data regarding the use of renal replacement therapy (RRT) in ABI, with a paucity of multicenter randomized controlled trials. When thoroughly evaluating the… Click to show full abstract
We agree that there are very little data regarding the use of renal replacement therapy (RRT) in ABI, with a paucity of multicenter randomized controlled trials. When thoroughly evaluating the existing trials comparing CRRT to intermittent hemodialysis (IHD), patients with ABI were excluded, were not identified, or they made up a small proportion of study participants (20%), and none compared the different modalities in these patients. The overall conclusions of no clear benefit of CRRT over IHD with respect to survival, length of stay, and renal recovery simply cannot be applied to the ABI population.
Journal Title: Chest
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!